China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version)

被引：37

作者：

Shi, Yuankai ^{[1
,2
]}

Sun, Yan ^{[1
,2
]}

Yu, Jinming ^{[14
]}

Ding, Cuimin ^{[15
]}

Wang, Ziping ^{[3
]}

Wang, Changli ^{[16
]}

Wang, Dong ^{[17
]}

Wang, Cunde ^{[19
]}

Wang, Zheng

Wang, Mengzhao ^{[4
]}

Zhi, Xiuyi ^{[5
]}

Lu, You ^{[20
]}

Feng, Jifeng ^{[22
]}

Liu, Yunpeng ^{[23
]}

Liu, Xiaoqing ^{[6
]}

Liu, Wei ^{[3
]}

Wu, Gang ^{[24
]}

Li, Xiaomei ^{[7
]}

Li, Kai ^{[16
]}

Li, Enxiao ^{[25
]}

Li, Wei ^{[26
]}

Chen, Gongyan ^{[27
]}

Chen, Zhengtang ^{[18
]}

Yu, Ping ^{[21
]}

Wu, Ning ^{[2
,8
]}

Wu, Milu ^{[28
]}

Xiao, Wenhua ^{[9
]}

Zhang, Li ^{[4
]}

Zhang, Yiping ^{[29
]}

Zhang, Shucai ^{[10
]}

Yang, Shujun ^{[31
]}

Song, Xia ^{[32
]}

Lin, Dongmei ^{[3
]}

Luo, Rongcheng ^{[33
]}

Shan, Li ^{[34
]}

Zhou, Caicun ^{[12
]}

Zhou, Zongmei ^{[8
]}

Zhao, Qiong ^{[30
]}

Hu, Chengping ^{[35
]}

Hu, Yi ^{[7
]}

Guo, Qisen ^{[14
]}

Chang, Jianhua ^{[13
]}

Huang, Cheng ^{[36
]}

Zeng, Xuan ^{[4
]}

Han, Baohui ^{[11
]}

Han, Xiaohong ^{[1
,2
]}

Jia, Bo ^{[1
,2
]}

Han, Ying ^{[1
,2
]}

Huang, Yu ^{[1
,2
]}

机构：

[1] Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Canc Hosp, Beijing, Peoples R China

[2] Peking Union Med Coll, Beijing, Peoples R China

[3] Beijing Canc Hosp, Beijing, Peoples R China

[4] Peking Union Med Coll Hosp, Beijing, Peoples R China

[5] Capital Med Univ, Beijing Xuanwu Hosp, Beijing, Peoples R China

[6] Chinese Peoples Liberat Army, Hosp 307, Beijing, Peoples R China

[7] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China

[8] Chinese Acad Med Sci, Dept Imaging Diagnost, Natl Canc Ctr, Canc Hosp, Beijing, Peoples R China

[9] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Beijing, Peoples R China

[10] Capital Med Univ, Beijing Chest Hosp, Beijing, Peoples R China

[11] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai, Peoples R China

[12] Tongji Univ, Shanghai Pulm Hosp, Shanghai, Peoples R China

[13] Fudan Univ, Canc Hosp, Shanghai, Peoples R China

[14] Shandong Prov Canc Hosp, Jinan, Peoples R China

[15] Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China

[16] Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China

[17] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China

[18] Third Mil Med Univ, Xinqiao Hosp, Chongqing, Peoples R China

[19] Yunnan Prov Canc Hosp, Kunming, Peoples R China

[20] Sichuan Univ, West China Hosp, Chengdu, Peoples R China

[21] Sichuan Canc Hosp, Chengdu, Peoples R China

[22] Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China

[23] China Med Univ, Hosp 1, Shenyang, Peoples R China

[24] Huazhong Univ Sci & Technol, Union Hosp, Wuhan, Peoples R China

[25] Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China

[26] Jilin Univ, Hosp 1, Changchun, Peoples R China

[27] Harbin Med Univ, Canc Hosp, Harbin, Peoples R China

[28] Qinghai Univ, Affiliated Hosp, Xining, Peoples R China

[29] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China

[30] Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China

[31] Henan Prov Canc Hosp, Zhengzhou, Peoples R China

[32] Shanxi Prov Canc Hosp, Taiyuan, Peoples R China

[33] Nanfang Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China

[34] Xinjiang Med Univ, Canc Hosp, Urumqi, Peoples R China

[35] Cent South Univ, Xiangya Hosp, Changsha, Hunan, Peoples R China

[36] Fujian Canc Hosp, Fuzhou, Peoples R China

来源：

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 13卷 / 01期

关键词：

GROWTH-FACTOR RECEPTOR; PHASE-II TRIAL; TYROSINE KINASE INHIBITORS; WHOLE-BRAIN RADIOTHERAPY; WILD-TYPE EGFR; 1ST-LINE TREATMENT; OPEN-LABEL; RADIATION-THERAPY; AMERICAN SOCIETY; PLUS CARBOPLATIN;

D O I：

10.1111/ajco.12608

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：87 / 103

页数：17

共 77 条

[1]

[Anonymous], ANN ONCOL S1

[2]

[Anonymous], 2015, J Clin Oncol

[3]

[Anonymous], 2015, ZHONGHUA ZHONG LIU Z, DOI [10.3760/cma.j.issn.0253-3766.2015.10.018, DOI 10.3760/CMA.J.ISSN.0253-3766.2015.10.018]

[4]

[Anonymous], 2016, NONSM CELL LUNG CANC

[5]

[Anonymous], LIN CHUANG ZHONG LIU

[6]

[Anonymous], J THORAC ONCOL S2

[7]

Argiris A, 2001, CANCER J, V7, P437

[8] Upfront association of carboplatin plus pemetrexed in patients with brain metastases of lung adenocarcinoma [J].

Bailon, Olivier ;

Chouahnia, Kader ;

Augier, Alexandre ;

Bouillet, Thierry ;

Billot, Segolene ;

Coman, Irene ;

Ursu, Renata ;

Belin, Catherine ;

Zelek, Laurent ;

Des Guetz, Gaetan ;

Levy, Christine ;

Carpentier, Antoine F. ;

Morere, Jean-Francois .

NEURO-ONCOLOGY, 2012, 14 (04) :491-495

[9] Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01) [J].

Barlesi, F. ;

Gervais, R. ;

Lena, H. ;

Hureaux, J. ;

Berard, H. ;

Paillotin, D. ;

Bota, S. ;

Monnet, I. ;

Chajara, A. ;

Robinet, G. .

ANNALS OF ONCOLOGY, 2011, 22 (11) :2466-2470

[10] Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: AVAPERL (MO22089) [J].

Barlesi, Fabrice ;

Scherpereel, Arnaud ;

Rittmeyer, Achim ;

Pazzola, Antonio ;

Tur, Neus Ferrer ;

Kim, Joo-Hang ;

Ahn, Myung-Ju ;

Aerts, Joachim G. J. V. ;

Gorbunova, Vera ;

Vikstrom, Anders ;

Wong, Elaine K. ;

Perez-Moreno, Pablo ;

Mitchell, Lada ;

Groen, Harry J. M. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (24) :3004-+

← 1 2 3 4 5 6 7 8 →